Could this player be heading into a new era of growth?

XBI has nearly 50 points of upside to reach its previous all-time high, and 2026 biotech industry conditions may help it get ...

Recent setbacks for the movement signal a potential turning point for the vaccine makers as the market picks up ...

YieldMax MRNA Option Income Strategy ETF is rated a Sell due to heightened downside risk and overvalued pipeline optimism.

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

I work with thousands of companies transforming their workforce with AI. The ones succeeding are taking decisive steps to ...

Some large merger & acquisition deals that could shake up the consumer goods and the food distribution industry, plus deals ...

But the company's pipeline tells a very different story, and contrarian investors are paying close attention. According to ...

For many businesses, the question isn’t whether people will use AI. With so many tools available, the real question is ...

In this article, we will look at Jim Cramer’s review of the S&P 500’s top performers and the Nasdaq 100’s biggest laggards ...

Throughout history, Christians have often believed Pontius Pilate was reluctant to condemn Jesus. History suggests otherwise, ...

Nancy has been a health news reporter and editor at Reuters for more than a decade, covering important medical research advances. She is the author of our twice-a-week Reuters Health Rounds newsletter ...